GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KDR, MAOA, MET, MIF, PPARA, SLC1A1, SMAD3, SRC, TEK, XDH |
11.0272 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
9.94951 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
9.94951 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, PTPN1, RELA, SRC, TEK, XDH |
9.47774 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, EGFR, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MIF, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, PTGES, RELA, SMAD3, SRC, TEK, XDH |
9.47407 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PTGES, RELA, RORC, SRC, TEK, TYR |
8.83791 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
8.83791 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
8.83791 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
8.83791 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
8.71811 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
8.57335 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, NUAK1, PTPN1, RELA, SRC, TEK, XDH |
8.57335 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PTGES, RELA, RORC, SMAD3, SRC, TEK, TYR |
8.30801 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
8.26892 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, F10, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
8.18126 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PPARA, PTGES |
8.0125 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.98542 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK |
7.62265 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
7.62265 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, XDH |
7.53815 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK |
7.53656 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PTGES, RELA, RORC, SMAD3, SRC, TEK, TYR |
7.44817 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALDH2, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GLO1, HMGCR, HSD17B3, HSPA1A, MIF, PIM1, PPARA, PTGES, TYR, XDH |
7.15953 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.04542 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.99251 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
6.92267 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK |
6.90664 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
6.85567 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, EGFR, FLT3, GRM1, HMGCR, INSR, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK, XDH |
6.81809 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
6.80845 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGES, RELA, SRC |
6.47 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK, XDH |
6.47 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
6.40382 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MAP3K7, MET, MIF, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK |
6.3891 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NR3C1, NUAK1, PTPN1, RELA, RORC, SMAD3, SRC, TOP2A |
6.28116 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
6.1939 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, TYR |
6.13641 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
6.05021 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, CA2, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, NR3C1, PPARA, RELA, SMAD3, SRC, TEK |
6.01206 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, EGFR, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.97102 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, EGFR, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.97102 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DUSP3, EGFR, F3, FABP4, HMGCR, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
5.9494 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.93086 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, RELA, RORC, SMAD3, SRC |
5.84614 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.77609 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.76059 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.7248 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, NR3C1, PTGES, RELA, RORC, SRC, TEK, TYR |
5.7205 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.71606 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.71606 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
5.6017 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.58212 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
5.55481 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, EGFR, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, NR3C1, RELA, RORC, SRC |
5.51596 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK |
5.43141 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
5.40474 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1B1, EGFR, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, NR3C1, RELA, RORC, SMAD3, SRC |
5.36012 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
5.36012 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
5.36012 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
5.36012 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
5.35703 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
5.34125 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CDC25B, CSNK2A1, EGFR, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, RELA, TEK |
5.34125 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.30166 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
5.28686 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SMAD3, SRC, TEK, TYR |
5.28582 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.28582 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
5.28578 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC |
5.28578 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
5.28409 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
5.22936 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SRC, TEK, XDH |
5.21773 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
5.21773 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.21179 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
5.21179 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PGR, PIM1, PPARA, RELA, RORC, SMAD3, SRC, TEK, TOP2A, TYR |
5.15378 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.11192 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
5.10333 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, NR3C1, PTGES, RELA, RORC, SRC, TYR |
5.10179 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, XDH |
5.06447 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, EGFR, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
5.03354 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.02503 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.02503 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, NR3C1, PGR, PIM1, PPARA, RELA, RORC, SRC |
5.02475 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.99435 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.97343 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
4.91213 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
4.88409 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, AR, CA2, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, NR3C1, PPARA, RELA, SRC, TEK |
4.84034 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.81543 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.75418 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.69561 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
4.69561 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HMGCR, HSD17B3, MAOA, TYR |
4.62114 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
4.60314 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
4.59756 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, EGFR, GRM1, GRM3, GRM5, GRM8 |
4.55031 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, CDC25B, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.53216 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, CA2, CYP1B1, EGFR, F3, HMGCR, HSPA1A, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SLC1A1, SMAD3, SRC, TEK |
4.5209 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, HMGCR, KDR, MAP2K1, MIF, PTPN1, SRC, TEK |
4.47632 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.47632 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, INSR, PPARA, RELA, SRC, TEK |
4.47113 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
4.42804 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
4.42753 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.41377 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
4.36835 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
4.36835 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.36763 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.36663 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
4.36119 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, HMGCR, MET, MIF, PPARA, PTGES |
4.25985 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, CDC25B, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
4.24469 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.24469 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
4.24351 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, CDC25B, EGFR, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
4.24351 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.23741 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR, HSD17B3 |
4.21461 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MIF, PTGES |
4.21268 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, RELA, SRC, TEK, TYR |
4.16717 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.12612 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
4.10706 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.09404 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MMP9, PGR, PIM1, PPARA, RELA, RORC, SMAD3, SRC, TEK, TYR |
4.08728 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, GRM1, HMGCR, HSPA1A, MMP2, PPARA, RELA, SMAD3, SRC, TEK, TYR |
4.06744 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
4.06662 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.06486 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, F3, FABP4, HMGCR, KDR, MAP2K1, MET, MIF, MMP12, PPARA, RELA, SMAD3, TEK |
4.04539 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, RELA, SMAD3, TYR |
4.03363 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, EGFR, FLT3, GRM5, IGF1R, INSR, MMP2, NR3C1, RELA, SMAD3, SRC |
4.01463 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
4.01463 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.01274 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
4.00575 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, GLO1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.00575 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HMGCR |
3.96216 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.92626 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, INSR, MAP2K1, MIF, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.85719 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
3.85719 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, RELA, SRC, TEK, TYR |
3.8272 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.804 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.75982 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
3.7472 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, HMGCR, KDR, MAP2K1, MIF, SRC, TEK |
3.72839 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
3.70124 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
3.69789 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, CA2, CACNA1C, CYP1B1, EGFR, F3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SLC1A1, SMAD3, SRC, TEK, XDH |
3.68086 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.67368 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, AR, CYP1A1, CYP1B1, EGFR, FLT3, NR3C1, RORC, SRC |
3.67368 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, INSR, RELA, SRC |
3.57072 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, NR3C1, RELA, SRC |
3.55053 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MIF, NUAK1, PTPN1, XDH |
3.55053 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, FLT3, MAP2K1, MET, MIF, PIM1, SRC, TEK, TYR |
3.52174 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.52174 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, SRC, TEK, TOP2A |
3.51412 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, TOP2A |
3.49329 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, MIF, SRC |
3.48554 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES |
3.48243 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.46381 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, ALDH2, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.43132 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.3956 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MAP3K7, MMP12, MMP2, PPARA, PTPN1, RELA, SMAD3, SRC, TEK |
3.38124 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, DUSP3, EGFR, GPR35, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, XDH |
3.37567 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.37567 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, EGFR, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SMAD3, SRC, TEK, XDH |
3.37038 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.37038 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, DUSP3, EGFR, GPR35, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, XDH |
3.3647 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES |
3.33324 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, XDH |
3.32515 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.32408 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.32387 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, MIF, PTPN1, SRC |
3.29691 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, GRM5, IGF1R, INSR, MMP2, RELA, SRC |
3.28783 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.28387 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.28187 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.28187 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.28187 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.26559 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.25893 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CACNA1C, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.25893 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
3.25477 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SRC |
3.16997 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, CYP19A1, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
3.14178 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, RELA, SMAD3, SRC |
3.14178 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.13704 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.13704 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, KDR, MMP12, PGR, SMAD3, TEK, XDH |
3.09536 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP9, PTPN1, RELA, SRC, XDH |
3.09287 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, EGFR, NR3C1, RELA, SRC |
3.09144 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, KDR, NR3C1, RELA, SRC |
3.06133 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.0321 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
3.0321 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GRIK5, INSR, MAOA, SLC1A1, SMAD3 |
3.03135 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, GRM5, IGF1R, INSR, MMP2, RELA, SRC |
3.03122 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HSPA1A, MAOA |
3.01955 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, NR3C1, SRC |
2.92088 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
2.87103 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
2.87103 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
2.86893 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.86893 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.84835 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HMGCR, PPARA, RORC, SRC, TEK |
2.80515 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.80515 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, APP, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, GPR35, GRM1, GRM5, SMAD3 |
2.80384 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, MIF, PIM1, SMAD3, SRC, TOP2A |
2.78309 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, RELA, SMAD3, SRC |
2.78309 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.75761 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.73331 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, PGR, PPARA, RORC, SRC, TOP2A |
2.73266 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, EGFR, HMGCR, KDR, MIF, SRC |
2.68213 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.66733 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PTPN1, RELA, SRC |
2.66733 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DUSP3, INSR |
2.63614 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.63614 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PTGES |
2.62483 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, F3, FABP4, FLT3, GLO1, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
2.59421 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, HSD17B2, HSD17B3, INSR, MAP2K1, MMP2, MMP9, PGR, SRC, TOP2A |
2.59084 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, EGFR, FLT3, NR3C1, RELA, SRC |
2.58262 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NUAK1, PPARA, PTGES, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A |
2.57462 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, CDC25B, CYP19A1, EGFR, HSD17B2, HSD17B3, INSR, MAP2K1, PGR, SRC |
2.57187 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, HMGCR, KDR, RELA, SRC |
2.5027 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, CACNA1C, CYP1B1, EGFR, GRM5, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, NUAK1, PTPN1, RELA, SRC, TEK |
2.49963 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES |
2.48369 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTPN1, SRC |
2.46748 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, EGFR, GRM1, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.46572 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, CYP1A1, HMGCR, MAP2K1, MIF, RELA |
2.45325 |
[BP] GO:0051591 |
None
|
APEX1, APP, RELA, TEK, TYR |
2.45002 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.44714 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.44714 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.44714 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.44714 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.44714 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGES |
2.43457 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
2.4296 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, SLC1A1 |
2.40233 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD17B3, TYR |
2.40233 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.38767 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, FABP4, HMGCR, HSPA1A, IGF1R, KDR, MAP2K1, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, XDH |
2.38767 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, EGFR, HSPA1A, IGF1R, INSR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TOP2A |
2.37945 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.37654 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.37654 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.37654 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.37654 |
[BP] GO:0051172 |
None
|
APEX1, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MIF, MMP12, MMP9, NR3C1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, XDH |
2.37654 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
2.35838 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, APP, CA12, CA2, CA7, CACNA1C, EGFR, GPR35, GRM1, GRM5, SMAD3 |
2.35423 |
[BP] GO:0046328 |
regulation of JNK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP3K7, PTPN1 |
2.3193 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.3157 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES |
2.3157 |
[BP] GO:0000186 |
activation of MAPKK activity
|
ADORA1, EGFR, GRM1, MAP3K7 |
2.3157 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.3157 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.3002 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, MIF, PTPN1, SRC |
2.27359 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD17B3, MIF, PTGES |
2.27094 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.26902 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.2592 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
APEX1, AR, EGFR, FLT3, INSR, NR3C1, RELA, SRC |
2.25711 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, KDR, MMP12, TEK |
2.255 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, XDH |
2.24818 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.24115 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, CSNK2A1, EGFR, HSPA1A, INSR, KDR, MAP3K7, MET, PPARA, PTPN1, RELA, SMAD3 |
2.22963 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, XDH |
2.22813 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, EGFR, PPARA, SMAD3 |
2.21121 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
2.21121 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.21121 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21121 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.19837 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.1823 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP3A4, MAOA |
2.17629 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.17629 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, FLT3, NR3C1, RELA, RORC, SRC |
2.17117 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.16577 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.16197 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, FABP3, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SMAD3, SRC, TOP2A |
2.15563 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
2.14819 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AR, AXL, CDC25B, CYP1A1, EGFR, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PGR, RORC, SMAD3, SRC, TEK, TOP2A |
2.13968 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, EGFR, HMGCR, MIF, MMP12, PTPN1, SMAD3, SRC |
2.13274 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SMAD3, SRC, TOP2A |
2.13006 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.12836 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.11984 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.11984 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AR, AURKB, CSNK2A1, DUSP3, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR3C1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, XDH |
2.1082 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CACNA1C, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, SLC1A1, TEK |
2.09611 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR |
2.07581 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, ALDH2, APP, CYP1B1, CYP3A4, HMGCR |
2.07581 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.07581 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, HSPA1A, MAP2K1, PTGES, SMAD3, XDH |
2.07475 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06443 |
[BP] GO:0006081 |
None
|
AKR1B10, CYP1B1, GLO1, RELA |
2.06443 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, RELA, SRC, TEK |
2.06179 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, HMGCR, MIF, PPARA, SMAD3, TEK |
2.05443 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, MIF, SMAD3 |
2.05443 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.05227 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PPARA, PTGES |
2.04833 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.03653 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.03653 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.03653 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.03653 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.03653 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.03653 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.03048 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PTPN1, RELA, SMAD3, SRC |
2.01238 |
[CC] GO:0043235 |
receptor complex
|
ABCG2, APP, EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, NR3C2, SMAD3 |
4.7683 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, F10, F3, FLT3, FUT7, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B2, HSD17B3, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, NR3C2, PGR, PIM1, PTGES, PTPN1, SLC1A1, SMAD3, SRC, TEK, TYR |
4.35238 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA1, ADORA3, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, EGFR, F10, F3, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC1A1, SMAD3, SRC, TEK |
4.27334 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADORA1, CA2, CA4, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK |
4.19975 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA1, ADORA3, APP, AXL, CA2, CA4, CACNA1C, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SRC, TEK |
3.74813 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, F10, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
3.72395 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PTGES, PTPN1, RELA, SMAD3, SRC, TOP2A, TYR, XDH |
3.5327 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.39698 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.26218 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, F10, FLT3, GRIA2, HMGCR, HSD11B1, HSD17B2, HSD17B3, NR3C2, PTGES, PTPN1 |
2.82435 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.82219 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.82219 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.65887 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B2, HSD17B3, IGF1R, INSR, KDR, MAOA, MET, NR3C2, PTGES, PTPN1, SLC1A1, SRC, TEK, TYR |
2.65395 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CYP19A1, FLT3, GRIK5, HMGCR, HSD17B3, HSPA1A, KDR, MAP2K1, PTPN1, XDH |
2.63614 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SLC1A1, SMAD3, SRC, TOP2A, TYR, XDH |
2.49122 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
2.43351 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.31454 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, GRIA2, HMGCR, HSD11B1, HSD17B2, HSD17B3, NR3C2, PTGES |
2.21314 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.11984 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.09128 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
11.0272 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTPN1, SRC, TEK, TOP2A, TYR, XDH |
9.47774 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, F10, F3, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
9.43908 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.86115 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.69791 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, TEK |
7.16793 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
7.01932 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.94835 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
6.3891 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.22017 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
6.10521 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1, SHBG |
6.01206 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, HSD17B1, NR3C1, NR3C2, PGR, RORC, SHBG |
5.98474 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
5.89766 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.84614 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC, SMAD3 |
5.80295 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP2A |
5.36012 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.21773 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.11192 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.88409 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.88017 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
4.75085 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.71046 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
4.55031 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, GLO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, TOP2A, TYR, XDH |
4.24081 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC |
4.15016 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.06662 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, TEK |
4.06662 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, TEK |
4.06662 |
[MF] GO:0043168 |
anion binding
|
ABCG2, APP, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTGES, RELA, SLC1A1, SRC, TEK, TOP2A, XDH |
4.06486 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, CYP3A4, F10, F3, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC, SHBG |
4.05224 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, GLO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, TOP2A, TYR, XDH |
4.04539 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.04172 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SMAD3, SRC |
3.99773 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
3.9269 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.84854 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.62514 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.52174 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, ADORA1, ALDH2, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SLC1A1, SRC, TEK, TOP2A, XDH |
3.49752 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.34184 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
3.3404 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD17B1, PTGES, SRC, XDH |
3.32482 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, F3, GRM5, HMGCR, HSPA1A, MET, MIF, NR3C1, PGR, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A |
3.30384 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.26837 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.26837 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.25401 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, APP, CSNK2A1, EGFR, FLT3, GRIK5, HMGCR, IGF1R, KDR, MAP3K7, MET, MIF, MMP9, PGR, RELA, SMAD3, TOP2A, TYR, XDH |
3.15332 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, MAP2K1, MAP3K7, SMAD3 |
2.99887 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.8832 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
2.88025 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.80515 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.7292 |
[MF] GO:0005524 |
ATP binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.67551 |
[MF] GO:0000166 |
nucleotide binding
|
ABCG2, ALDH2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.63614 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCG2, ALDH2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.63512 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, XDH |
2.60153 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.56667 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.53037 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.48369 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, PGR, PPARA, RORC |
2.44714 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, PGR, PPARA, RORC |
2.44714 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.44714 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.44714 |
[MF] GO:0019902 |
phosphatase binding
|
EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
2.3782 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.37326 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.37326 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.31066 |
[MF] GO:0019900 |
None
|
AURKB, CDC25B, DUSP3, EGFR, GRM5, NR3C1, PTPN1, RELA, SMAD3, SRC, TOP2A |
2.2688 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, CYP19A1, CYP1A2, XDH |
2.26024 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.24759 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.21121 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.21121 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.21121 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.21121 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.21121 |
[MF] GO:0019901 |
None
|
CDC25B, DUSP3, EGFR, GRM5, NR3C1, PTPN1, RELA, SMAD3, SRC, TOP2A |
2.11068 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.1082 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.03653 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.03653 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.02965 |